Limitations of the therapeutic use of superoxide dismutase Due to the instability, high immunogenicity, low cellular uptake and less in vivo circulation of the half-life of superoxide dismutase, their clinical use as therapeutic agents is very limited
Hinweis zur verantwortlichen Stelle Die verantwortliche Stelle fr die Datenverarbeitung auf dieser Website ist: Dr
JH and XF consulted literatures and wrote the manuscript in equal contribution
Earlier studies suggest that semaglutide (sold as Ozempic, Wegovy, and Rybelsus) may cause more digestive issues, including diarrhea, than older GLP-1 medications like liraglutide (Saxenda and Victoza)
Side effects are uncommon and typically very mild, like a little soreness or redness at the injection site
Reduce and fitting the face pores